The safety profile of varicella vaccine: a 10-year review

The Journal of Infectious Diseases
S A GaleaR G Sharrar

Abstract

Varivax (varicella virus vaccine live [Oka/Merck]; Merck), a live attenuated varicella vaccine, is indicated for vaccination against varicella in appropriate individuals > or =12 months of age. The 10-year safety profile for Varivax is described using data submitted to Merck from routine global postmarketing surveillance, combined with information from a Varicella Zoster Virus Identification Program, which uses polymerase chain reaction (PCR) analysis to identify the presence and strain of VZV in selected specimens. There were 16,683 reports worldwide voluntarily submitted to Merck, for an overall reporting rate of 3.4 reports/10,000 doses of vaccine distributed. PCR analysis of vesicular rashes that occurred within the first 2 weeks after vaccination was more likely to identify wild-type varicella-zoster virus (VZV), whereas the presence of Oka VZV was generally associated with vesicular rashes that occurred 15-42 days after vaccination. Reports of breakthrough varicella that occurred >42 days after vaccination were associated with wild-type VZV. Among 697 herpes zoster reports, PCR analysis identified Oka VZV in 57 reports and wild-type VZV in 38 reports. There were no primary neurologic adverse events associated with Oka VZV...Continue Reading

References

Sep 9, 2000·JAMA : the Journal of the American Medical Association·R P WiseP R Krause
Dec 15, 2000·Vaccine·R G SharrarA A Gershon
Sep 27, 2003·The Journal of Infectious Diseases·Anne A Gershon
Jun 14, 2006·The Journal of Pediatrics·Richard GrossbergD Scott Schmid

❮ Previous
Next ❯

Citations

Jan 30, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M FahlbuschP Lehmann
May 6, 2010·The Journal of Infectious Diseases·Moeun SonAnne A Gershon
Aug 4, 2012·British Medical Bulletin·Andrew Flatt, Judy Breuer
Jun 8, 2012·Journal of Virology·Anca SelariuHua Zhu
Oct 29, 2009·Emerging Infectious Diseases·Taketo OtsukaMakoto Uchiyama
Jan 29, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hung Fu TsengSteven J Jacobsen
May 18, 2011·Journal of Crohn's & Colitis·Oliver Waters, Tariq Ahmad
Dec 23, 2011·Journal of Neurovirology·Jason J ChenMichael D Gershon
Feb 22, 2011·Expert Review of Vaccines·Nigel W CrawfordJim P Buttery
Jan 10, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Takahiro AokiRyoji Hanada
Feb 14, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A Sauerbrei
Jun 28, 2011·Expert Opinion on Emerging Drugs·Graciela Andrei, Robert Snoeck
Apr 18, 2012·Vaccine·Neal A HalseyUNKNOWN Causality Working Group of the Clinical Immunization Safety Assessment network
Mar 6, 2016·Vaccine·Tetsushi YoshikawaMasahiro Ohashi
Dec 3, 2014·Vaccine·Kouki Murakami, Yasuko Mori
Apr 2, 2009·Dermatologic Therapy·Brenda L Bartlett, Stephen K Tyring
Apr 2, 2009·Dermatologic Therapy·Rosella CreedParisa Ravanfar
Apr 14, 2016·International Journal of Rheumatology·Maria Francisca Moraes-FontesNuno Riso
Aug 3, 2013·Microbiology and Immunology·Masaaki MatsuuraYasuko Mori
Apr 2, 2014·Reviews in Medical Virology·Mark Quinlivan, Judy Breuer
Aug 21, 2015·Human Vaccines & Immunotherapeutics·Skerdi HaviariPhilippe Vanhems
Sep 26, 2015·Journal of the Pediatric Infectious Diseases Society·Christiana SmithEdwin J Asturias
Mar 18, 2016·Expert Opinion on Drug Safety·Nicola Principi, Susanna Esposito
Apr 14, 2016·Ophthalmology·Kimberly D TranAnat Galor
Nov 26, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nicolas C IssaLindsey R Baden
Feb 26, 2011·Vaccine·R K KandaJ Breuer
Jul 26, 2015·Science China. Life Sciences·Wei WangNingShao Xia
May 13, 2015·The Journal of Pediatrics·Mary KimYvonne E Chiu
Jan 1, 2015·Nature Reviews. Disease Primers·Anne A GershonKoichi Yamanishi
Dec 3, 2013·Acta Microbiologica Et Immunologica Hungarica·Julia Sarkadi
Aug 29, 2013·Human Vaccines & Immunotherapeutics·Jessica LeungMona Marin
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
Jun 15, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Joanne F ChouTrudy N Small
Apr 19, 2015·Clinics in Dermatology·Adena E Rosenblatt, Sarah L Stein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.